Small is Smarter: Nano MRI Contrast Agents - Advantages and Recent Achievements.

@article{Gao2016SmallIS,
  title={Small is Smarter: Nano MRI Contrast Agents - Advantages and Recent Achievements.},
  author={Zhenyu Gao and Tiancong Ma and Enyu Zhao and Dominic Docter and Wensheng Yang and Roland H. Stauber and Mingyuan Gao},
  journal={Small},
  year={2016},
  volume={12 5},
  pages={
          556-76
        }
}
Many challenges for advanced sensitive and noninvasive clinical diagnostic imaging remain unmatched. In particular, the great potential of magnetic nano-probes is intensively discussed to further improve the performance of magnetic resonance imaging (MRI), especially for cancer diagnosis. Based on recent achievements, here the concepts of magnetic nanoparticle-based MRI contrast agents and tumor-specific imaging probes are critically summarized. Advances in their synthesis, biocompatible… 
Recent advancements in biocompatible inorganic nanoparticles towards biomedical applications.
TLDR
The state-of-the-art of the preparation of biocompatible inorganic nanoparticles and bioconjugation strategies for obtaining target-specific nanoprobes and the advancements in sensitive tumor imaging towards diagnosis and visualization of the abnormal signatures in the tumor microenvironment are highlighted.
Multifunctional gold nanoparticles as smart nanovehicles with enhanced tumour-targeting abilities for intracellular pH mapping and in vivo MR/fluorescence imaging.
TLDR
A series of pH-responsive magnetic resonance and fluorescence imaging (MRI/FI) dual-modal "nanovehicles" are developed and tested that may provide a new method for studying the role of pH during cancer diagnosis and treatment.
Nano-Magnetic Resonance Imaging (Nano-MRI) Gives Personalized Medicine a New Perspective
TLDR
Nano-MRI is potentially able to observe structures which cannot be seen using today’s molecular imaging, with sensitivities of many billions of times better than MRI as currently used in hospitals, for example.
Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imaging.
TLDR
The state-of-the-art developments and the latest applications of USPIO nanoparticles as MRI contrast agents to discuss their advantages and future prospects are focused on.
Gadolinium functionalized carbon dots for fluorescence/magnetic resonance dual-modality imaging of mesenchymal stem cells.
TLDR
Gd-CDs promote the proliferation of human mesenchymal stem cells (hMSCs), which is tracked by the fluorescence/Magnetic Resonance dual-modality imaging of hMSCs by the Gd- CDs, and shows strong and stable fluorescence with excitation-independent emission behavior.
A mesoporous polydopamine nanoparticle enables highly efficient manganese encapsulation for enhanced MRI-guided photothermal therapy.
TLDR
Developed mesoporous polydopamine nanoparticles prepared on MRI and PTT combined theranostic nanoplatforms have uniform morphology, good stability and biocompatibility, and have excellent antitumor efficacy in HeLa tumor-bearing mice.
pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
TLDR
The synthesized nanocomposites exhibited highly sensitive MRI contrast function no matter in solution, cells or in vivo by synergistically enhancing positive and negative magnetic resonance imaging signals.
Potential detection of cancer with fluorinated silicon nanoparticles in 19F MR and fluorescence imaging.
TLDR
A one-pot microwave synthesis of fluorinated silicon nanoparticles (19FSiNPs) is reported, for detection of cancer cells and tumors and demonstrated that these nanoprobes significantly enhanced in vivo 19F/1H MRI contrast in rats with non-small cell lung tumors.
Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T1-Weighted Magnetic Resonance Imaging and Chemotherapy.
TLDR
The MR Imaging and chemotherapy results on the cancer cells and tumor-bearing mice reinforce that the DOX@ES-MION3@RGD2@mPEG3 nanoparticles are promising for high-resolution T1-weighted MR imaging and precise chemotherapy of tumors.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 190 REFERENCES
Magnetically engineered semiconductor quantum dots as multimodal imaging probes.
TLDR
A review of QD/magnetic nanoparticles combined with magnetic resonance imaging contrast agents within a single nanoparticle platform for biomedical research and related clinical applications concludes with an outlook for future biomedical imaging and the identification of key challenges in reaching clinical applications.
Magneto-plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging.
TLDR
Results show that Au-Fe nanoalloys are excellent candidates as multimodal MRI-CT-SERS imaging agents and biocompatibility, exploitability for in vivo use and capability of selective accumulation in tumors by enhanced permeability and retention effect.
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
TLDR
MRI has further advanced by the development of contrast agents that enable more specific and clearer images and enlargements of detectable organs and systems, leading to a wide scope of applications of MRI not only for diagnostic radiology but also for therapeutic medicine.
Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
TLDR
A novel and facile synthesis of hollow manganese oxide nanoparticles (HMONs) and their potential application as multifunctional agents for simultaneous MR imaging and drug delivery is reported and greatly improved relaxivities are demonstrated.
Magnetic/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo.
TLDR
New approaches for size control synthesis of magnetic/upconversion fluorescent NaGdF4:Yb,Er nanocrystals and their applications for imaging tiny tumors in vivo are reported.
Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
  • N. Lee, T. Hyeon
  • Chemistry, Materials Science
    Chemical Society reviews
  • 2012
TLDR
How MRI contrast effects can be improved by controlling the size, composition, doping, assembly, and surface properties of iron-oxide-based nanoparticles is discussed.
Environment-responsive Nanophores for Therapy and Treatment Monitoring via Molecular MRI Quenching
TLDR
It is demonstrated that clinically approved iron oxide nanoparticles (Ferumoxytol) can be utilized to carry one or multiple drugs and is more effective than the free drug in vitro and in vivo, without subjecting the drugs or the carrier nanoparticle to any chemical modification.
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.
TLDR
This study revealed that Luminescent hybrid nanoparticles suited for dual modality imaging freely circulate in the blood vessels without undesirable accumulation in lungs and liver.
Anti-biofouling polymer-decorated lutetium-based nanoparticulate contrast agents for in vivo high-resolution trimodal imaging.
TLDR
Compared with previous lanthanide fluorides, these nanoprobes exhibit more advantages, such as facile construction process and nearly total excretion from the animal body within a month, which promise the use of PEG-UCNPs as a safe and efficient nanoparticulate contrast agent for potential application in multimodal imaging.
Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging.
TLDR
A reverse-microemulsion-based synthesis protocol is employed to produce 25 nm ICG-doped silica nanoparticles (NPs) that have the potential to act as theranostic agents by combining photodynamic therapy through the absorption of NIR irradiated light.
...
1
2
3
4
5
...